A Pilot Study Assessing the Effectiveness of Use of Guided Imagery for Treatment of Pain and Symptom Management in Women With Post-mastectomy Pain Syndrome

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05408741
Collaborator
(none)
62
1
2
30.9
2

Study Details

Study Description

Brief Summary

To learn if using guided imagery and deep breathing techniques can help with pain management in patients who have post-mastectomy pain syndrome.

Condition or Disease Intervention/Treatment Phase
  • Other: The Intervention Group
  • Other: The Control Group
N/A

Detailed Description

OBJECTIVES:
Primary objective:

-To evaluate the effectiveness of use of Guided imagery and deep breathing techniques in pain management compared to control arm in patients with post-mastectomy pain syndrome who don't receive intervention and only receive standard care.

Secondary objective:

To evaluate effectiveness of Guided imagery and deep breathing techniques in symptom cluster management including fatigue, sleep, depression, and anxiety and in general quality of life compared to control arm who don't receive intervention and only receive standard care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Pilot Study Assessing the Effectiveness of Use of Guided Imagery for Treatment of Pain and Symptom Management in Women With Post-mastectomy Pain Syndrome
Actual Study Start Date :
Jun 6, 2022
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1 (The Intervention Group)

Participants will receive guided imagery and deep breathing technique exercises.

Other: The Intervention Group
Participants will complete a 20-minute guided imagery exercise (which includes deep breathing exercises) every day at home using the selected app and/or resource you downloaded at the beginning of this study.

Experimental: Group 2 ( The Control Group)

Participants will not receive any relaxation techniques. Participants will receive the current standard of care.

Other: The Control Group
Participants will continue to receive your current care, but will not receive guided imagery or deep breathing exercises from a social worker.

Outcome Measures

Primary Outcome Measures

  1. The change in pain severity score and the change in pain interference score, measured by brief pain inventory short form. Brief Pain Inventory: 0-10 No Pain-0 Worst Pain-10 [through study completion, an average of 1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Breast Cancer patients who were performed mastectomy in previous 12 months

  2. Chronic post-mastectomy pain syndrome (≥3 months)

  3. Patients who report 5-10 on the baseline pain severity score or 5-10 on the baseline pain interference score

  4. Patients ≥ 18 years old and ≤ 70 years old

  5. Must understand and read English, sign a written informed consent, and follow protocol requirements

  6. If on medication for anxiety or depression, stable dose of medications for management of anxiety or depression symptoms for at least six weeks prior to enrollment with no plans to change medications in the subsequent four weeks. Increases or decreases allowed within drug class, but changing drug class will make patient in-evaluable

Exclusion Criteria:
  1. Current chemotherapy or radiation

  2. Pending surgery during treatment

  3. Other chronic pain diagnosis besides post mastectomy pain syndrome (PMPS)

  4. Suicidal ideation

  5. Diagnosis of a formal thought disorder (e.g., schizophrenia)

Contacts and Locations

Locations

Site City State Country Postal Code
1 MD Anderson Cancer Center Houston Texas United States 77051

Sponsors and Collaborators

  • M.D. Anderson Cancer Center

Investigators

  • Principal Investigator: Uzondu Osuagwu, MD, M.D. Anderson Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT05408741
Other Study ID Numbers:
  • 2020-1104
  • NCI-2022-04827
First Posted:
Jun 7, 2022
Last Update Posted:
Jun 8, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 8, 2022